News
Healthcare costs are expected to rise by nearly 8% in 2025 ... In addition, more people are using GLP-1 weight loss drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, to treat diabetes, obesity ...
Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...
The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...
The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in. | Novo ...
The first significant rift within MAGA under Trump 2.0 emerged with the passage of the Big Beautiful Bill, which extended the ...
A mother-of-three who shed two stone in just nine weeks thanks to a skinny jab has warned users of a painful side-effect that ...
Sustainability awareness remains strong in the Middle East, with 75% of respondents expressing concern about climate change.
Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. Buying ...
The Secretary of Health Services wants every American to use a wearable device in the next four years. Experts say it's a ...
The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results